Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
NCT07785986Completed
Randomised, double-blind trial of curcumin in exercise-induced muscle damage (EIMD) (3 arms), sponsored by Universidad de Valladolid. Primary endpoint: Exercise-induced muscle damage at 72 hours. Started Aug 2026; status: completed.
Beyond the preview
Study design, results and competitive context are available in the Gosset platform where reported.
Available in the Gosset platform where reported.
Available in the Gosset platform where reported.
See how Gosset can support your research on NCT07785986.